Dostarlimab + Chemotherapy For The Treatment Of Primary Advanced Or Recurrent Endometrial Cancer (Pa/Rec): Analysis Of Progression Free Survival (Pfs) And Overall Survival (Os) Outcomes By Molecular Classification In The Engot-En6-Nsgo/Gog-3031/Ruby Trial
Dostarlimab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Dostarlimab + Chemotherapy For The Treatment Of Primary Advanced Or Recurrent Endometrial Cancer (Pa/Rec): Analysis Of Progression Free Survival (Pfs) And Overall Survival (Os) Outcomes By Molecular Classification In The Engot-En6-Nsgo/Gog-3031/Ruby Trial ### Output: Dostarlimab